149 related articles for article (PubMed ID: 19821765)
1. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
Bentmann A; Kawelke N; Moss D; Zentgraf H; Bala Y; Berger I; Gasser JA; Nakchbandi IA
J Bone Miner Res; 2010 Apr; 25(4):706-15. PubMed ID: 19821765
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
[TBL] [Abstract][Full Text] [Related]
3. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation.
Kawelke N; Bentmann A; Hackl N; Hager HD; Feick P; Geursen A; Singer MV; Nakchbandi IA
J Bone Miner Res; 2008 Aug; 23(8):1278-86. PubMed ID: 18348696
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
5. Integrin expression and function on human osteoblast-like cells.
Gronthos S; Stewart K; Graves SE; Hay S; Simmons PJ
J Bone Miner Res; 1997 Aug; 12(8):1189-97. PubMed ID: 9258748
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
7. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
8. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.
Zimmerman D; Jin F; Leboy P; Hardy S; Damsky C
Dev Biol; 2000 Apr; 220(1):2-15. PubMed ID: 10720426
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1-integrin levels.
Gronowicz GA; McCarthy MB
Endocrinology; 1995 Feb; 136(2):598-608. PubMed ID: 7530648
[TBL] [Abstract][Full Text] [Related]
10. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
[TBL] [Abstract][Full Text] [Related]
11. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
13. A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix.
Lutter AH; Hempel U; Wolf-Brandstetter C; Garbe AI; Goettsch C; Hofbauer LC; Jessberger R; Dieter P
J Cell Biochem; 2010 Apr; 109(5):1025-32. PubMed ID: 20108253
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast cytoskeletal modulation in response to mechanical strain in vitro.
Meazzini MC; Toma CD; Schaffer JL; Gray ML; Gerstenfeld LC
J Orthop Res; 1998 Mar; 16(2):170-80. PubMed ID: 9621891
[TBL] [Abstract][Full Text] [Related]
15. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
[TBL] [Abstract][Full Text] [Related]
16. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation.
Cui C; Kaartinen MT
Bone; 2015 Mar; 72():43-52. PubMed ID: 25460579
[TBL] [Abstract][Full Text] [Related]
17. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
18. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.
Owen TA; Aronow M; Shalhoub V; Barone LM; Wilming L; Tassinari MS; Kennedy MB; Pockwinse S; Lian JB; Stein GS
J Cell Physiol; 1990 Jun; 143(3):420-30. PubMed ID: 1694181
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix.
McCarthy AD; Uemura T; Etcheverry SB; Cortizo AM
Int J Biochem Cell Biol; 2004 May; 36(5):840-8. PubMed ID: 15006636
[TBL] [Abstract][Full Text] [Related]
20. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
